PAYTON E ATTARD
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant HOUSTON, TX NPI 1609532944
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$779.56
- Category: General Payments
- Program years: PY2021–2022
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $524.09 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.09 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $207.62 | 2 |
| Regeneron Healthcare Solutions, Inc. | $115.61 | 1 |
| GENZYME CORPORATION | $101.60 | 1 |
| Novo Nordisk AS | $62.99 | 1 |
| Evofem Biosciences, Inc. | $24.04 | 1 |
| Organon LLC | $12.23 | 2 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1022255335 | Organon LLC | $2.58 | 04/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1022255339 | Organon LLC | $9.65 | 04/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898758827 | Novo Nordisk Inc | $62.99 | 02/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 900677015 | Evofem Biosciences, Inc. | $24.04 | 02/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 914648675 | AstraZeneca Pharmaceuticals LP | $109.01 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 914732745 | AstraZeneca Pharmaceuticals LP | $98.61 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 927499373 | Regeneron Healthcare Solutions, Inc. | $115.61 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 938876147 | GENZYME CORPORATION | $101.60 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.